Antibody Production Market To Reach USD 58.1 Billion By 2032 CAGR: 12.4%. Report By DataHorizzon Research

Fort Collins, Colorado, Oct. 01, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, "Antibody Production Market Size, Growth, Share, Statistics Analysis Report By Product (Consumable and Instrument), By Process (Upstream, Downstream), By Type (Monoclonal, Polyclonal), By Region, and Segment Forecasts 2023-2032."        

According to DataHorizzon Research, The antibody production market was valued at USD 18.2 Billion in 2022 and is expected to reach USD 58.1 Billion by 2032 with a CAGR of 12.4%. The global report on antibody production is spread across market segments, regional analysis, and forecasts. It offers a comprehensive overview of the scenarios in the healthcare industry for vaccine and antibody production with key takeaways.

Antibodies are created naturally in the body's immune system; also, antibodies can be synthetically created to protect the body from foreign molecules and diseases. An increased risk of chronic diseases like diabetes, cancer, autoimmune diseases, and cardiovascular disease has resulted in an increased demand for antibody production. The increasing prevalence of cancer patients poses an urge to maximize antibody production.

According to the US FDA, nearly 1.7 million cancer patients are diagnosed yearly, indicating the need for antibody production to cure cancer. The rise of COVID-19 also paved the way for the antibody production market in 2021, and since then, numerous startups have emerged to create antibodies and vaccines to prevent the spread of coronavirus in the body.

The humanization of antibodies has made it possible to clinically apply biologics to cure life-threatening diseases that require a long time. According to the USFDA, over the past five years, antibodies have become the selling drugs in the pharmaceutical market. This has driven the market for antibody production to a great extent.

Increasing investments in research and development of monoclonal antibodies is a great opportunity for antibody production. According to the US FDA, since 2008-48 new mAbs have been approved, with a global market share of 61 mAbs by 2017. Additionally, 18 new antibodies were granted approval by the US FDA between 2018 and 2019. 

Request Sample Report: 

https://datahorizzonresearch.com/request-sample-pdf/antibody-production-market-2264

Report Snapshot:

Antibody Production Market Report Highlights:

• The global Antibody Production market size is anticipated to grow to USD 58.1 billion at a CAGR of 12.4% by 2032.

• The antibody production market growth factors include the ongoing research and development and spending on vaccines and antibodies to combat the rising life-threatening diseases.

• Consumable is the leading segment for antibody production due to the ongoing demand for diagnostics and therapeutics.

• The downstream dominated the global market in 2022 due to their popularity in production. The downstream technique also relays effectiveness and efficiency in the production processes.

• Due to the ongoing research and development, North America is a leading region for antibody production. The availability of patient pools and the rise in the geriatric population with huge unmet medical needs is expected to propel the market growth in the coming years.

• Some prominent players in the Antibody Production market report include Medtronic, Cisco, IBM Corporation, SAP SE, Infosys, Qualcomm, EKso Bionics, and BL Healthcare. 

Buy This Research Report: 

https://datahorizzonresearch.com/checkout-page/antibody-production-market-2264

Key Developments in the Industry:

• In a recent article published by Springer Nature Journal, excerpts from the article indicate that auto-immune diseases can aggravate the natural production of auto-antibodies driven by COVID-19, which is why aging can be a trigger to develop severe COVID-19 symptoms in these patients.

• In 2023, South Korea’s Samsung Biologics and Pfizer partnered to mass-produce cancer antibodies.

• In 2023, ModeX Therapeutics Inc. received a Biomedical Advanced Research and Development Authority (BARDA) Contract to design multi-specific antibodies against viral infectious diseases. 

Looking Exclusively For Region/Country Specific Report?

https://datahorizzonresearch.com/ask-for-customization/antibody-production-market-2264

OR

Ask For Discount 

https://datahorizzonresearch.com/ask-for-discount/antibody-production-market-2264

Antibody Production Market Report Segmentation:

Antibody Production Market, By Product (2023-2032)

• Consumable
• Instrument

Antibody Production Market, By Process (2023-2032)

• Upstream
• Downstream

Antibody Production Market, By Type (2023-2032)

• Monoclonal
• Polyclonal

Antibody Production Market, By Region (2023-2032)

• North America
  • U.S.
  • Canada

• Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific

• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America

• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of the Middle East & Africa 

About DataHorizzon Research:

DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.

Contact:

Mail: sales@datahorizzonresearch.com

Ph: +1-970-672-0390

Website: https://datahorizzonresearch.com/

Follow Us: LinkedIn

Recent Publications

Oral Care Market 2023 to 2032
Cancer Diagnostics Market 2023 to 2032
Status Epilepticus Market 2023 to 2032
Stem Cells Market 2023 to 2032
Coronary Stent Market 2023 to 2032